Fluicell AB (OSTO:FLUI) Interest Expense: kr-0.17 Mil (TTM As of Mar. 2026)

What is Fluicell AB Interest Expense?

Fluicell AB OSTO:FLUI +2.72% 54 Interest Expense is kr-0.17 Mil as of Mar. 2026. GuruFocus rates OSTO:FLUI with a GF Score™ of 54/100 and a GF Value™ of kr34.52 (Fairly Valued). The stock has 4 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fluicell AB's interest expense for the three months ended in Mar. 2026 was kr -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr-0.17 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fluicell AB's Operating Income for the three months ended in Mar. 2026 was kr 3.29 Mil. Fluicell AB's Interest Expense for the three months ended in Mar. 2026 was kr -0.03 Mil. Fluicell AB's Interest Coverage for the quarter that ended in Mar. 2026 was 99.76. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fluicell AB (OSTO:FLUI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fluicell AB's Interest Expense for the three months ended in Mar. 2026 was kr-0.03 Mil. Its Operating Income for the three months ended in Mar. 2026 was kr3.29 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was kr0.00 Mil.

Fluicell AB's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	3.292	/	-0.033
	=	99.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Fluicell AB Interest Expense Historical Data

* Premium members only.

The historical data trend for Fluicell AB's Interest Expense can be seen below:

Fluicell AB Interest Expense Chart

Fluicell AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-0.03

-0.05

-0.03

-0.08

-0.11

Fluicell AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.03	-0.07	-0.06	-0.00	-0.03

54GF Score

Fluicell AB OSTO:FLUI

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Fluicell AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.17 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of kr-0.17 Mil mean?

Fluicell AB (OSTO:FLUI) has a Interest Expense of kr-0.17 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fluicell AB and its competitors.

Is Fluicell AB's Interest Expense too high?

Fluicell AB's current Interest Expense is kr-0.17 Mil. Overall, Fluicell AB has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Fluicell AB's Interest Expense compare to VRTX and REGN?

Fluicell AB's Interest Expense of kr-0.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Biotechnology company?

A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fluicell AB and its competitors. Fluicell AB's current Interest Expense is kr-0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Fluicell AB stock overvalued right now?

Based on GuruFocus' analysis, Fluicell AB (OSTO:FLUI) is currently considered Fairly Valued. The stock's GF Value™ is kr34.52, compared to a current price of kr34.00 — trading 1.5% below its estimated fair value. The current Interest Expense is kr-0.17 Mil. Fluicell AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Fluicell AB (OSTO:FLUI), the current Interest Expense is kr-0.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fluicell AB (OSTO:FLUI) Overvalued in 2026?

Based on GuruFocus' analysis, Fluicell AB stock appears to be undervalued. The current stock price of kr34.00 is trading 1.5% below its estimated GF Value™ of kr34.52. GuruFocus considers Fluicell AB to be Fairly Valued.

Key valuation signals for OSTO:FLUI:

Interest Expense: kr-0.17 Mil
GF Value™: kr34.52 vs. price of kr34.00 (1.5% below fair value)
GF Score™: 54/100 with 4 warning signs

No single metric tells the full story. See the OSTO:FLUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fluicell AB Business Description

Industry Healthcare Biotechnology

Comparable Companies OSTO:GUARD OSTO:2CUREX XSAT:DBP B OSTO:MODTX OSTO:MAGLE OSTO:PILA XSAT:RESP OSTO:BIOSGN OSTO:NANECH OSTO:EXPRS2 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 5J90:Germany

Address Flojelbergsgatan 8C, Molndal, Gothenburg, SWE, 431 37

Website https://www.fluicell.com

Fluicell AB is a Swedish life science company that conducts development in regenerative medicine and human tissue-based screening models for drug development, with a particular focus on the areas of type 1 diabetes, cardiac safety screening models, and kidney diseases. The company's platform for the production of human tissue that is based on Fluicell's technology for high-resolution 3D bioprinting, and which enables the creation of tissue-based products for use in drug development and regenerative medicine.

54GF Score

Get the complete analysis for OSTO:FLUI

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr34.00

Price

kr34.52

GF Value

View OSTO:FLUI Analysis

See Interest Expense data for all stocks →